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PIKE: A Nuclear GTPase that Enhances PI3Kinase
Activity and Is Regulated by Protein 4.1N
not been established. Ran is one predominantly nuclear
ras protein (Rush et al., 1996), implicated in RNA export
from the nucleus, protein import, mitotic regulation, and
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and Solomon H. Snyder* cell cycle progression. MxB, a large GTPase homolo-
Johns Hopkins University School of Medicine gous to dynamin and induced by interferon, occurs in
Departments of Neuroscience, Pharmacology the nucleus, but is predominantly cytoplasmic (Melen
and Molecular Sciences, and Psychiatry et al., 1996; Melen and Julkunen, 1997).
725 North Wolfe Street Our studies of protein 4.1N (Walensky et al., 1999;
Baltimore, Maryland 21205 Ye et al., 1999) led to an interest in nuclear effects of
cytoskeleton proteins via plasma membrane associated
tyrosine kinase receptors. Protein 4.1N is a neuronal
Summary selective isoform of the erythrocyte membrane cytoskel-
eton protein 4.1R. Protein 4.1N binds the nuclear mitotic
While cytoplasmic PI3Kinase (PI3K) is well character- apparatus protein (NuMA), a nonhistone nuclear protein
ized, regulation of nuclear PI3K has been obscure. A that leaves the nucleus at mitosis and is associated with
novel protein, PIKE (PI3Kinase Enhancer), interacts poles of the mitotic spindle (Lydersen and Pettijohn,
with nuclear PI3K to stimulate its lipid kinase activity. 1980; Price and Pettijohn, 1986; Compton et al., 1992;
PIKE encodes a 753 amino acid nuclear GTPase. Domi- Yang and Snyder, 1992). 4.1N mediates the antimitotic
nant-negative PIKE prevents the NGF enhancement of antiproliferative actions of NGF (Ye et al., 1999).
PI3K and upregulation of cyclin D1. NGF treatment In the yeast two-hybrid analysis that identified interac-
also leads to PIKE interactions with 4.1N, which has tions of 4.1N and NuMA, we also observed interactions
translocated to the nucleus, fitting with the initial iden- with another protein, which we have shown to be a
tification of PIKE based on its binding 4.1N in a yeast nuclear GTPase that binds to PI3K and activates it. We
two-hybrid screen. Overexpression of 4.1N abolishes have designated this protein the phosphoinositide ki-
PIKE effects on PI3K. Activation of nuclear PI3K by nase enhancer (PIKE).
PIKE is inhibited by the NGF-stimulated 4.1N translo-
cation to the nucleus. Thus, PIKE physiologically mod-
ulates the activation by NGF of nuclear PI3K. Results
Introduction
Binding of 4.1N to PIKE
We conducted yeast two-hybrid analysis using the
Phosphoinositide 3-kinase (PI3K), which phosphory-
C-terminal domain (679–879 amino acids) of 4.1N as bait.lates phosphoinositides on the D-3 position, regulates
Eleven of the thirteen clones include a variety of overlap-a variety of cellular functions (Auger et al., 1989; Majerus
ping fragments of the protein, which we have designatedet al., 1990; Cantley et al., 1991; Krugmann and Welch,
PIKE. We observe interactions between the C-terminal1998). PI3K is activated by growth and differentiation
portion of 4.1N(4.1N-CTD) and PIKE (1–318) regardlessproteins such as nerve growth factor (NGF) (Ohmichi et
of which protein is used as bait or prey. By contrast,al., 1992; Ashcroft et al., 1999; Neri et al., 1999; Tanaka
the N-terminal portion of 4.1N(4.1N-NTD) fails to interactet al., 1999), platelet derived growth factor (PDGF)
with PIKE. In HEK 293 cells, transfected HA-PIKE binds(Auger et al., 1989; Joly et al., 1994; Franke et al., 1995),
to 4.1N-CTD but not to 4.1N-NTD, consistent with ourinsulin receptor substrate-1 (IRS-1) (Ruderman et al.,
yeast two-hybrid findings (Figure 1A).1990; D’Mello et al., 1997) and CD28 (Ward et al., 1993).
Coimmunoprecipitation studies demonstrate interac-These growth factors also activate GTPases, predomi-
tions between 4.1N and PIKE in intact cells. Two differ-nantly of the ras family, which in turn activate PI3K by
ent length fragments of PIKE bind to 4.1N, whereas Elk1,binding to its p110 subunit (Rodriguez-Viciana et al.,
employed as a control, fails to bind to 4.1N (Figure 1B).1994, 1996, 1997; Stoyanov et al., 1995). The direct path-
Robust binding also occurs between full-length PIKEway from tyrosine phosphorylated receptors to PI3K
and the 4.1N-CTD. (Figure 1C). Interactions are the sameand activation of PI3K by GTPase proteins function syn-
regardless of whether 4.1N or PIKE contain HA or Mycergistically (Stephens et al., 1993; Klinghoffer et al.,
tags.1996; Vanhaesebroeck et al., 1997).
Of the 11 yeast two-hybrid fragments of PIKE thatPI3K also occurs in the nucleus (Neri et al., 1994; Kim,
bind 4.1N, the smallest one that interacts robustly com-1998; Lu et al., 1998; Marchisio et al., 1998; Bavelloni
prises the N-terminal 173 amino acids. Using truncationset al., 1999). Stimulation of cells with NGF activates
nuclear PI3K with nuclear accumulation of 3-phosphory- of this fragment, we find that the first 23 amino acids
lated phosphoinositide lipids (Neri et al., 1994; Tanaka of PIKE may be sufficient for binding 4.1N (Figure 1D).
et al., 1999). Ras proteins regulating nuclear PI3K have Experiments with GST-fusion proteins also show that
the 1–23 amino acid fragment of PIKE interacts robustly
with 4.1N, as do the other fragments at the extreme* To whom correspondence should be addressed (e-mail: ssnyder@
jhmi.edu). N-terminal portion of PIKE (Figure 1E).
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Figure 1. 4.1 and PIKE Associate In Vitro and In Vivo
(A) In vitro binding of HA-PIKE (1–318) to GST-4.1-CTD. Lysates from HEK 293 cells transfected with HA-PIKE (1–318) cDNA were incubated
with GST, GST-4.1N-NTD, or GST-4.1N-CTD. Bound proteins were visualized by Western immunoblotting with anti-HA antibody.
(B) Coimmunoprecipitation of HA-PIKE with Myc-4.1N-CTD. HEK293 cells were cotransfected with Myc-4.1N CTD and HA-tagged PIKE (1–318,
1–673), HA-Elk1 respectively. After immunoprecipitation with anti-HA antibody, bound proteins were visualized by Western blotting with anti-
Myc antibody.
(C) Coimmunoprecipitation of full-length PIKE with 4.1N CTD. HEK293 cells were respectively cotransfected with Myc- or HA-tagged PIKE
and 4.1N CTD. After immunoprecipitation with anti-Myc antibody, bound proteins were visualized by Western blotting with anti-HA antibody.
(D) The N-terminal 23 amino acids of PIKE associate with 4.1N CTD in the yeast two-hybrid system. Truncations of the N terminus of PIKE
were constructed in pPC86 and cotransfected with pPC97 4.1N CTD plasmids into the Y190 yeast. Only the 1–73, 1–112, and 1–173 constructs
show both histidine prototrophy and b-gal activity. Other constructs are negative in either assay.
(E) The N-terminal 23 amino acids of PIKE bind to 4.1N in vitro. Lysates from HEK 293 cells transfected with 4.1N cDNA were incubated with
GST-PIKE N-terminal truncations. The bound protein 4.1N was visualized by Western immunoblotting with anti-4.1N antibody.
Structure of PIKE However, we identified from database a gene on human
chromosome 12 (human cosmid clone 6e5, accessionScreen of a lambda phage cDNA library of rat brain
reveals a 2.3 kb open reading frame encoding a 753 number 4,001,539) that has 91% identity over the entire
PIKE cDNA. This human gene contains the three proline-amino acid sequence comprising the full length of PIKE
(Figure 2A). We observe substantial homology in the rich domains that human KIAA0167 lacks, indicating that
human cosmid clone 6e5 contains human PIKE. Thus,C-terminal portion of PIKE to several GTP binding pro-
teins including centaurin g-a, Rab7, and R-Ras (Figure KIAA0167 and PIKE have homologous GTPase/PH do-
mains but appear to be distinct genes. On the other2B). Besides the ras-like domain (aa 402–686), PIKE
contains a PH domain (aa 670–704) immediately to the hand, we found a rat EST clone (EST202125; accession
number AI007674), which is identical to the 250 nucleo-C-terminal side of the ras-like domain. In the N-terminal
portion of PIKE, we observe three proline-rich domains tides at the 39 end of PIKE, including the same stop
codon. This provides confirmation of the sequence de-(aa 28–34; 182–189; and 353–362) (Figure 2C).
Amino acid residues 387–752 of PIKE are virtually termined for our clone. We have replicated our own
sequence determination 6 times.identical to residues 56–420 of human cDNA KIAA0167
(accession number NM_014770). Over this same region,
PIKE and KIAA0167 have 89% nucleic acid identity. Un- Tissue Distribution and Intracellular Localization
of PIKElike PIKE, KIAA0167 contains an extension that includes
the C-terminal half of the PH domain indicated in PIKE, Northern blot analysis of various rat tissues reveals a
prominent band in the brain at about 5.0 kb (Figure 3A).an ARF-GAP domain, and ankyrin repeats. KIAA0167
has the same domain structure as D. melanogaster Besides the 80 kDa PIKE, Western analysis shows a 65
kDa band that is prominent in brain, and faint in lung,Centaurin g-1a and C. elegans hypothetical protein
Y39A1A.15b, indicating that KIAA0167 is the human or- heart, and liver. Both the 80 kDa and the small-size
bands are blocked by preincubating the anti-serum withtholog of Centaurin-g-1a. Conceivably, PIKE might be
an alternatively spliced form of Centaurin g-1a in rat. recombinant PIKE fragment. Both bands are evident
PIKE, Nuclear GTPase
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Figure 2. PIKE Encodes a Novel GTPase
(A) Full length amino acid sequence of PIKE.
(B) PIKE is a 753 amino acid protein with sequence homology to the defined GTP binding domain of Centaurin g-a, Rab7, and R-Ras.
(C) PIKE has three proline rich domains (PRD) in the N terminus, and in the C terminus, a Ras-like domain and a Pleckstrin homology (PH)
domain.
with different antibodies raised against distinct frag- and [32P]GTP to PIKE (Figure 4A). The C-terminal portion
of PIKE, which contains the consensus GTP bindingments of PIKE N terminus (data not shown).
In situ hybridization shows PIKE exclusively in neu- sequence, binds both [32P]ATP and [32P]GTP, while the
N-terminal portion of the protein fails to display suchrons, with the highest levels in the hippocampus, in CA1,
and the dentate gyrus. In the cerebellum, signal is low in binding. Binding is saturable, being almost completely
displaced by 10 mM unlabeled nucleotide. Both GTPthe molecular layer, but enriched in granule and Purkinje
cells. and ATP bind to PIKE with Kd values of 16 nM and 41
nM, respectively, and PIKE binds about 0.6 mol of GTP-Subcellular fraction reveals PIKE exclusively in the
nuclear fraction (Figure 3D). The lower molecular weight g-S/mol and 0.9 mol of ATP-g-S/mol of protein, respec-
tively. Unlabeled ATP-g-S reduces [35S]GTP-g-S bindingimmunoreactive bands are not evident in nuclei but are
enriched in endoplasmic reticulum/Golgi and synapto- to PIKE with half-maximal inhibition at about 30–40 nM
ATP, similar to its Kd for direct binding to PIKE.somal fractions. The identity of the fractions is substanti-
ated by the exclusive appearance of the nuclear protein PIKE possesses GTPase activity. Like GST-Ras, PIKE
hydrolyzes bound GTP into GDP, while GST-4.1N CTDNuMA in the nuclear fraction, the mitochondrial protein
cytochrome C in the mitochondrial fraction, and the fails to do so (Figure 4B). Though 4.1N binds to PIKE,
Golgi protein GM130 in the endoplasmic reticulum/Golgi it fails to stimulate PIKE GTPase activity. Using estima-
fraction. tions from the release by PIKE of 32Pi from [g-32P]GTP,
In transfected HEK293 cells, HA-tagged PIKE staining the turnover number of PIKE for GTPase activity is 0.018
occurs exclusively in nuclei, whose identity is confirmed min21, compared to 0.007 min21 for GST-Ras.
by DAPI staining (Figure 3E). The nuclear localization of PIKE is detected in the homogenate and P1 (unbroken
PIKE is the same whether its lysine 413 and serine 414 cells and nuclei) fractions (Figure 4C). As PIKE occurs
are mutated to alanine and asparagine respectively, or in nuclear fractions, we examined the influence of NGF
HA is tagged at the N or C terminus. By contrast, staining treatment of PC12 cells on the activation of nuclear
for a-tubulin is extranuclear. Thus, the lower molecular PIKE. NGF treatment augments PIKE binding to GTP
weight immunoreactive band, which is cytosolic, does 5-fold at about 0.5 hr. Activity declines at 4 hr, and by
not reflect a smaller form of nuclear PIKE protein but is 24 hr has returned to baseline levels (Figure 4D).
instead a cross-reactive band. 4.1N translocates to the nucleus of PC12 cells follow-
ing NGF treatment, but with a slower time course than
what we have observed for activation of PIKE. 4.1NNGF Augments the GTP Loading of PIKE and Leads
appears in the nucleus only in very small levels one hrto Its Interactions with 4.1N in the Nucleus
after NGF treatment, with peak levels at 24–48 hr (Ye etThe consensus GTP binding domain in the C-terminal
al., 1999). We examined the influence of NGF treatmentportion of PIKE suggests that it possesses GTPase ac-
tivity. We have directly demonstrated binding of [32P]ATP of PC12 cells on the association of 4.1N with PIKE in
Cell
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Figure 3. Tissue Distribution of PIKE
(A) Rat multiple tissue Northern blot hybrid-
ized with a probe derived from the N-terminal
portion of PIKE. A 5 kb transcript is enriched
in brain.
(B) Rat multiple tissue Western blot probed
with affinity-purified mouse anti-PIKE anti-
body. PIKE is expressed as an 80 kDa protein
only in brain. An unidentified 65 kDa band
cross-reacts with PIKE antibody in brain,
heart, lung, and liver.
(C) Neuronal distribution of PIKE. In situ hy-
bridization shows PIKE enriched in cerebel-
lum, cortex, and hippocampus. Under high
magnification, PIKE is expressed only in neu-
rons with virtually no signal evident in glial
cells. In the cerebellum, signal is very low in
the molecular layer but enriched in the gran-
ule cell and the Purkinje cell layers. At high
magnification, intense signal is evident in
most or all Purkinje cells and in most or all
granule cells.
(D) Subcellular localization of PIKE. The 80
kDa band reflecting PIKE occurs exclusively
in the nuclear fraction. The lower molecular
weight immunoreactive bands are not evident
in nuclei but are enriched in endoplasmic re-
ticulum/Golgi and synaptosomal fractions.
The identity of the fractions is substantiated
by the exclusive appearance of the nuclear
protein NuMA in the nuclear fraction, the mi-
tochondrial protein cytochrome C in the mito-
chondrial fraction, and the Golgi protein
GM130 in the endoplasmic reticulum/Golgi
fraction.
(E) Immunofluorescent staining of HA-PIKE in HEK 293 cells. HA-tagged PIKE was transfected into HEK 293 cells, which were then stained
with rabbit polyclonal anti-HA antibody and mouse monoclonal anti-a-tubulin antibody. Nuclei were stained with DAPI.
the nucleus (Figure 4E). NGF treatment produces a time- preparations preloaded with GTP-g-S but not for prepa-
rations preloaded with GDP (Figure 5B).dependent increase in levels of PIKE associated with
To ascertain the portion of PIKE that binds to PI3K,4.1N. PIKE is first demonstrable at 1 hr in the immuno-
we first cotransfected HEK 293 cells with various frag-precipitate with substantially higher levels at 24 hr and
ments of PIKE together with p85 (Figures 5C–5E). p85peak values at 48 hr. The activation of PIKE by NGF
binds robustly to PIKE and binding is the same for wild-prior to nuclear translocation of 4.1N indicates that these
type PIKE as PIKE with the GTP binding lysine-413 mu-two events are not likely to be causally linked. NGF does
tated to alanine and serine-414 to asparagine. Bindingnot alter the total concentration of PIKE (Figure 4E) or
is dependent on the N-terminal 23 amino acids of PIKE,4.1N in PC12 cell lysates (data not shown). Equal
as it is substantially reduced in forms of PIKE lackingamounts of 4.1N are immunoprecipitated with 4.1N anti-
these 23 amino acids. Deletion of the N-terminal 261body at all time intervals after NGF treatment (Fig-
amino acids of PIKE abolishes binding. Deletion of theure 4E).
PH domain at the C terminus of PIKE does not interfereTo assess whether the interaction of PIKE and 4.1N
with binding. However, deletion of the C-terminal 40%is dependent upon guanine nucleotides in PC12 cells,
of PIKE, eliminating the GTP binding domain, abolisheswe incubated glutathione beads bound to GST-4.1N
binding.with lysates of HEK293 cells transfected with HA-PIKE
Structural requirements for PIKE binding to p110 dif-(Figure 4F). Binding of PIKE 4.1N is not influenced by
fer somewhat from binding to p85 (Figures 5E and 5G).the presence of GTP-g-S or GDP-b-S.
As with p85, p110 binding is not affected by the
K413AS414N mutation or by deletion of the C-terminal
PIKE Binds to PI3Kinase PH domain from PIKE. Whereas removal of the GTP
To look for direct interactions between PIKE and PI3K, binding area of PIKE abolishes binding to p85, this dele-
we isolated His-PIKE on nickel beads, loaded the beads tion only causes a modest reduction in binding to p110.
with GTP-g-S or with GDP, then incubated them with While deletion of the N-terminal 23 amino acids of PIKE
lysates of HEK293 cells that had been transfected with greatly reduces binding to p85, the same deletion does
PI3K with an HA tag for the p85 subunit and a myc tag not influence binding to p110. Like p85, p110 binding
for the p110 subunit (Figure 5A). Western blot analysis to PIKE is abolished by deletion of the N-terminal third
reveals robust binding of PIKE to p85 for PIKE prepara- of the molecule. In control experiments, we have demon-
tions preloaded with GTP-g-S but not for preparations strated that all the transfected proteins are expressed
to a similar extent (Figures 5D and 5F).preloaded with GDP. PI3K activity is demonstrable for
PIKE, Nuclear GTPase
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Figure 4. NGF Augments the GTP Loading of
PIKE and Leads to Its Interactions with 4.1N
in the Nucleus
(A) PIKE selectively binds to [32P]ATP/GTP.
Purified His-PIKE (1–262), His-PIKE (263–
753), His-PIKE (full-length), and Ni21 beads
(control) were incubated with [32P]ATP or
[32P]GTP respectively in the presence or ab-
sence of excess unlabeled ATP or GTP. After
extensive washing, bound radioactivity was
counted in a scintillation counter. Binding is
saturable, being almost completely displaced
by 10 mM unlabeled nucleotide.
(B) PIKE is a GTPase. Purified His-PIKE (0.5
mg) was incubated with [a-32P]GTP for 1 hr
at 378C. The extent of GTP hydrolysis was
assessed by thin layer chromatography. GST-
Ras (0.5 mg) was used as a positive control,
and 2 mg GST-4.1N CTD as a negative control.
Although GST-4.1N CTD binds to His-PIKE,
it fails to stimulate PIKE’s GTPase activity.
(C) Subcellular distribution of PIKE in PC12
cells. PIKE is found in the pellet fractions of
PC12 cells. H, homogenate; P, pellet; and S,
supernatant. P1 fraction contains unbroken
cells and nuclei, while P2 is composed of ER/
Golgi and mitochondria.
(D) NGF increases PIKE’s GTP loading in
PC12 cells. PIKE was immunoprecipitated
from the nuclear fraction of PC12 cells, which
were metabolically labeled with [32P]H3PO4 for
4 hr and treated with NGF for varying periods
of time. The bound GTP and GDP were sepa-
rated on TLC. The bound GTP increases 5
fold around 30 min after NGF treatment.
(E) 4.1N coimmunoprecipitates with PIKE in
response to NGF treatment. PC12 cells were
treated with 50 ng/ml NGF and, at the indi-
cated times, cells were lysed and immuno-
precipitated with anti-4.1N antibody. Copre-
cipitated PIKE was detected by Western
blotting. NGF treatment does not alter overall
PIKE expression in whole cell lysates. The same amount of the 4.1N protein was immunoprecipitated in each lane.
(F) HA-tagged PIKE association with 4.1N in vitro is not GTP dependent. One mM GTP-g-S, GDP-b-S, or buffer alone was added into HA-
PIKE-transfected lysate before incubating with purified GST-4.1N CTD. The bound protein was visualized with anti-HA antibody by Western
blotting.
To clarify whether PIKE directly associates with both and PIKE, but lacking P85. Cotransfection of 4.1N into
cells transfected with wild-type PIKE abolishes the PIKEp85 and p110, we cotransfected HEK293 cells with p85
(aa 1–515) that lacks the p110 binding domain and vari- induced activation of PI3K activity (Figure 6A). This loss
of activation is associated with the failure of PIKE toous fragments of PIKE. We observe the same interac-
tions between p85 (aa 1–515) and various fragments coprecipitate with PI3K in cells that have been cotrans-
fected with 4.1N, indicating that 4.1N competes withof PIKE as with full-length p85. We also cotransfected
HEK293 cells with p110 (aa 123–1023) that lacks the PI3K for binding to PIKE (Figure 6B).
To directly test the notion that 4.1N competes withp85 binding domain and various fragments of PIKE, and
observe the same associations as with full-length p110 PI3K for binding to PIKE, we transfected varying
amounts of 4.1N into cells that were also transfected(data not shown).
with p110, p85 and PIKE (Figure 6C). Robust binding of
p110 to PIKE is abolished by progressively increased
PIKE Activates PI3K and 4.1N Blocks
levels of 4.1N transfection.
This Activation
To assess the functional relevance of interactions be-
tween PIKE and PI3K, we cotransfected HEK293 cells PIKE Mediates Stimulation by NGF of Nuclear
PI3K Activity and Upregulation of Cyclin D1with p110, p85, PIKE, and 4.1N in various combinations
(Figure 6A). Catalytic activity occurs in cells transfected NGF influences various events in PC12 cells with mark-
edly different temporal features. Within a few minuteswith both p110 and p85 but not with p110 alone. Co-
transfection with PIKE leads to a quadrupling of enzyme after treatment with NGF, the GTPase activity of ras-
like proteins and of PI3K is augmented in the cytoplasmactivity. The p85 regulatory subunit of PI3K is critical,
as we observe no activity in cells transfected with p110 (Ridley et al., 1992; Rodriguez-Viciana et al., 1994, 1997;
Cell
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Figure 5. PIKE Associates with PI3K
(A) PIKE binding to PI3K is GTP dependent.
The purified His tagged PIKE or Ni21 beads
alone (control) were loaded with 1 mM GTP-
g-S or GDP, then incubated with the lysate
of HEK293 cells, which were transfected with
HA-p85/Myc-p110. The bound proteins were
visualized with anti-HA antibody.
(B) Association of PI3K activity with PIKE in
vitro. The amount of activity stably associ-
ated with the beads is shown. PI3K activity
bound to the GTP-loaded PIKE is substan-
tially higher than on the GDP loaded protein.
(C) Diagram of PIKE constructs used in the
coimmunoprecipitation experiments.
(D and E) Both the N and C terminus are re-
quired for PIKE association with p85. HA-p85
and Myc- tagged PIKE constructs were co-
transfected into HEK293 cells. p85 was im-
munoprecipitated with anti-HA antibody, and
bound proteins were visualized by Western
blot with anti-Myc antibody. Similar levels of
all Myc-PIKE constructs were expressed in
all experiments (E).
(F and G) PIKE associates with p110. Myc-
p110 and HA-tagged PIKE constructs were
cotransfected into HEK293 cells, and p110
was immunoprecipitated by anti-p110 rabbit
polyclonal antibody. The bound proteins
were visualized by Western blot with anti-HA
antibody. Similar levels of all HA-PIKE con-
structs were expressed in all experiments (F).
Altun-Gultekin and Wagner, 1996). Antimitotic influ- establish a casual relationship, we utilized a dominant-
negative form of PIKE for retroviral infection of PC12ences and neurite extension occur at about 12–24 hr
(Hagag et al., 1986; Milbrandt, 1988; Baetge and Ham- cells. We developed the dominant-negative construct
by making point mutations in PIKE’s well-conservedmang, 1991). If PIKE mediates the NGF activation of
nuclear PI3K, then activation of PIKE and of nuclear GTPase domain.
PIKE’s lysine 413 and serine 414, thought to bind toPI3K should display similar temporal properties. Nuclear
PIKE is activated at about 0.5 hr (Figure 4B). We observe GTP, were mutated to alanine and asparagine respec-
tively (Feig and Cooper, 1988). Activation of PI3K bymaximal activation of nuclear PI3K activity in the immu-
noprecipitate complex of p110 at about 0.5 hr following PIKE is GTP-dependent (Figure 5B). PIKE does bind to
PI3K in the presence of GDP, though less well thanNGF treatment of PC12 cells, the same as peak activa-
tion of PIKE (Figure 7A). By 4 hr, enzyme activity has with GTP (Figure 5A). To examine the PIKE mutants’
activation of PI3K, we cotransfected HEK293 cells withreturned almost to baseline levels.
If the activation of PI3K in the nucleus is through the p110, p85, PIKE (K413A), PIKE (S414N), and PIKE
(K413AS414N) in various combinations. Cotransfectionassociation with nuclear PIKE, then NGF should activate
PI3K associated with immunoprecipitates of endoge- with wild-type PIKE leads to a quadrupling of enzyme
activity. However, PIKE (S414N) and PIKE (K413AS414N)nous PIKE. Accordingly, we immunoprecipitated PC12
cells with PIKE antibody at various times after NGF treat- fail to activate PI3K activity (Figure 7B). We utilized PIKE
(K413AS414N) as a dominant-negative incorporated intoment and monitored PI3K activity in the immunoprecipi-
tates. PI3K activity is maximally activated at 30 min with a retrovirus, which was infected into PC12 cells. Follow-
ing NGF treatment, PI3K activity was monitored at vari-a time course identical to that of PI3K immunoprecipi-
tates. Selectivity for the nuclear translocation of 4.1N ous time points. In contrast to the quadrupling of PI3K
activity in control cells 0.5 hr after NGF, no increaseand p110 is evident by the absence of translocation for
a-tubulin following NGF treatment (Figure 7C). occurs at any time point in the dominant-negative in-
fected cells (Figure 7A).The temporal correlation for PIKE and PI3K activation
by NGF suggests a link between the two events. To PC12 cells treated with NGF undergo a G1 cell-cycle
PIKE, Nuclear GTPase
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Figure 6. PIKE Enhances PI3K Activity and
4.1N Blocks This Activation
(A) TLC for PI3K activity assays. HEK293 cells
were transfected with the indicated expres-
sion constructs. PI3K was immunoprecipi-
tated by anti-Myc antibody and assayed for
in vitro lipid kinase activity. Wortmannin (20
nM) inhibition shows that the kinase activity
is specific.
(B) 4.1N abrogates PIKE association with
PI3K. The Myc-p110 immunoprecipitates
were probed by Western blot with anti-PIKE
antibody. Equal amounts of Myc-p110 were
immunoprecipitated from each condition
(top). 4.1N inhibits PIKE binding to p110
(bottom).
(C) 4.1N competes with PI3K for binding to
PIKE. Myc-p110, HA-p85, and His-PIKE were
cotransfected into HEK 293 cells with 0, 2.5,
5, 7.5, 10, or 12.5 mg 4.1N plasmid. His-PIKE
was isolated on Ni21 beads. Coprecipitated
Myc-p110 was visualized by Western blot
with anti-Myc antibody. Equal amounts of
Myc-p110 and PIKE were confirmed with Myc
and PIKE antibodies. Progressive increases
in 4.1N expression occur with transfection of
increasing amounts of plasmids.
arrest and differentiate with extension of neurites. This PI3K, activating the latter. PIKE has three proline-rich
domains and a PH domain. The SH3 domain of P85G1 arrest is well documented by the G1-phase-specific
cyclin D1, which is dramatically increased in the nuclei might bind to the proline-rich domain of PIKE, as SH3
and proline-rich domains of proteins are frequently as-of PC12 cells by NGF treatment (Yan and Ziff, 1995; van
Grunsven et al., 1996; Ye et al., 1999). PI3Kinase activity sociated (Prasad et al., 1993; Kapeller et al., 1994; Plei-
man et al., 1994; Yu et al., 1994). PH domains bind tois required for the expression of cyclin D1 in many types
of cells (Gille and Downward, 1999; Takuwa et al., 1999). lipids and so might interact with the lipid substrates
attached to PI3K.To examine the role of PIKE in these events, we infected
PC12 cells with PIKE (K413AS414N) retrovirus, then We clarified how PIKE activates PI3K depending on
the presence of its two subunits with PIKE being abletreated the cells with NGF, and analyzed cyclin D1’s
expression level (Figure 7D). In control cells, cyclin D1’s to bind independently to each of the two subunits p85
and p110. Transfected by itself, p110 lacks catalyticconcentration is enhanced 2.5- and 4-fold, respectively,
after 2 and 4 days NGF treatment; however, in virus- activity but acquires it following cotransfection with p85.
PIKE transfection quadruples this activity. PIKE can acti-infected cells, cyclin D1 is not altered by NGF. NGF
treatment does not affect cyclin B1 protein level. To vate PI3K only when both p110 and p85 are expressed,
not with p110 alone. This suggests that PIKE alone canfurther evaluate how the PIKE mutant influences nuclear
cyclin D1, we employed immunocytochemistry. About not prevent p110 denaturation but may facilitate the
stabilizing effect of p85 on p110.20%, 45%, and 65% of nuclei, respectively, stain for
cyclin D1 after 0, 2, and 4 days NGF treatment, compared NGF treatment of PC12 cells activates PIKE and nu-
clear PI3K with peaks at 30 min, whereas NGF activatesto only 20% to 25% in the virus-infected cells (Fig-
ure 7E). the cytoplasmic GTPases of the ras family as well as
cytoplasmic PI3K much more rapidly with peak activityTo ascertain whether PIKE is required for neurite out-
growth in PC12 cells, we monitored neurite extension in 5–10 min (Carter and Downes, 1992; Rodriguez-Vici-
ana et al., 1994, 1997). These observations suggest thatin PC12 cells infected with the dominant-negative PIKE
(K413AS414N) retrovirus. PC12 cells in the presence of PIKE mediates the NGF activation of nuclear PI3K, a
conclusion established by experiments in dominant-NGF (50 ng/ml) for 4 days develop a network of neurite
outgrowth, with 80% 6 3% of control and 75% 6 4% negative PIKE (K413AS414N) retrovirus–infected PC12
cells, where activation by NGF of nuclear PI3K is abol-in the virus-infected cells elaborating neurites at least
two cell bodies in length. Thus, PIKE and nuclear PI3K ished.
Cytoplasmic PI3K activation requires activated recep-seem to be required for NGF-induced cell-cycle arrest,
but not for neurite outgrowth. tor tyrosine kinases (e.g., PDGFR, EGFR, CD28, etc.) or
GTPase proteins such as Ras. However, none of these
known PI3K activators are present in nucleus. Our dis-Discussion
covery that the nuclear GTPase, PIKE, enhances nuclear
PI3K activity indicates that PIKE may be the nuclearIn the present study, we have discovered a novel protein,
PIKE, which possesses GTPase activity and is exclu- counterpart of Ras. These findings provide a molecular
basis for the regulation of nuclear PI3K.sively localized to the nucleus where it binds 4.1N and
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Figure 7. NGF Stimulates Nuclear PI3K Ac-
tivity with a Similar Time Course as Its Activa-
tion of PIKE
(A) PIKE is required for the activation by NGF
of nuclear PI3K. PC12 cells (control or domi-
nant-negative PIKE retrovirus infected) were
treated with 50 ng/ml NGF for the indicated
times, nuclei were isolated and lysed. p110
was immunoprecipitated from the lysate with
rabbit polyclonal anti-p110 antibody. PI3K
activity assays were performed using the im-
munoprecipitate. Maximal activation of nu-
clear PI3K activity occurs at 0.5 hr in control
cells, while activation is abolished in the dom-
inant-negative retrovirus infected cells.
(B) Mutations in the GTPase domain of PIKE
abolish its activation of PI3K. HEK293 cells
were transfected with the indicated expres-
sion constructs. PI3K was immunoprecipi-
tated by anti-Myc antibody and assayed for
in vitro lipid kinase activity. Transfection with
wild-type PIKE augments PI3K activity 3- to
4-fold, while no activation is evident with
different forms of PIKE with point mutations
in the GTPase domain.
(C) NGF treatment elicits nuclear transloca-
tion of PI3K and 4.1N with different time
courses. Maximal increases in nuclear 4.1N
are not evident until 24–48 hr, but occur at
1–4 hr for PI3K. a-tubulin levels do not change
with time in nonnuclear and nuclear fractions.
(D) PIKE regulates the cyclin D1 expression
in PC12 cells. PC12 cells were infected with
dominant-negative PIKE (K413AS414N) ret-
rovirus, then treated with 50 ng/ml NGF for 2
and 4 days. The protein expression levels of
cyclin D1 and cyclin B1 were analyzed with
Western blot. The PIKE dominant-negative
mutant inhibits the upregulation of cyclin D1
by NGF.
(E) Immunofluorescent staining PC12 cells with cyclin D1. About 20%, 45%, and 65% of nuclei, respectively, stain for cyclin D1 after 0, 2,
and 4 days NGF treatment, compared to only 20% to 25% in the virus-infected cells.
NGF treatment activates PIKE in the nucleus. Several which coincides with the appearance of nuclear 4.1N,
might involve 4.1N sequestering PIKE away from nuclearproteins translocate to the nucleus following NGF treat-
ment and thus are candidates to activate PIKE. Exam- PI3K. The decline of PIKE’s NGF-induced GTPase acti-
vation takes place at about the same time and so alsoples include the NGF receptor TrkA itself as well as MAP
kinase (Yankner and Shooter, 1979, Sano et al., 1995; may participate in the decline of nuclear PI3Kinase.
Our findings suggest the following model for the tem-Salehi et al., 1996; Boglari et al., 1998). Stimulation of
cells with NGF activates nuclear PI3K associated with poral features of NGF’s differential regulation of cyto-
plasmic and nuclear PI3K. Within a few minutes follow-an accumulation in the nucleus of 3-phosphorylated
phosphoinositide lipids (Neri et al., 1994; Tanaka et al., ing NGF treatment, cytoplasmic PI3K is activated and
translocated from the cytoplasm to the plasma mem-1999). It has been shown before that phosphoinositide
lipids bind to PH domain and activate dynamin GTPase brane. This activation involves direct binding of SH2
domains of p85 to the phosphotyrosine portion of theactivity (Melen et al., 1996). In our studies, PI3K translo-
cates to the nucleus following NGF treatment with a growth factor receptor (Whitman et al., 1985; Kaplan et
al., 1987; Klinghoffer et al., 1996; Hallberg et al., 1998;time course that resembles the activation of PIKE. In
preliminary experiments, we treated PIKE with different Ming et al., 1999) as well as binding of p110 to members
of the ras family. Somewhat later, with a peak at aboutphospholipids, including phosphatidylinositol 4,5-bis-
phosphate (PI-4,5-P2) and phosphatidylinositol 3,4,5- 30 min, PIKE is activated and PI3K is translocated to
the nucleus and activated, presumably by PIKE. Stilltrisphosphate (PI-3,4,5-P3), but failed to detect PIKE’s
activation (data not shown). later, 4.1N translocates to the nucleus where it binds
to PIKE and inactivates it. This binding interferes withThe binding of 4.1N to PIKE prevents its interactions
with nuclear PI3K, which may influence the regulation interactions of PIKE and PI3K, and we speculate that
this may account in part for diminution of the upregu-of PI3K by NGF. Thus, NGF causes 4.1N to translocate
to the nucleus over a period of hours, lagging behind lated PI3K activity. At about the same time, PIKE’s
GTPase activity declines, which may also contribute tothe translocation of PI3K and the peak activation of PIKE
elicited by NGF. The decline of activated nuclear PI3K, the fall in nuclear PI3K activity.
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Coimmunoprecipitation and In Vitro Binding AssaysTargets of cytoplasmic PI3K have been studied exten-
The experimental procedures for coimmunoprecipitation and in vitrosively. The lipid products of PI3K in the cytoplasm acti-
binding assays are the same as described (Ye et al., 1999). For thevate a variety of kinases including Akt and PDK1 (Alessi
GTP-dependent association between His-PIKE and PI3K, assays
et al., 1997; Frech et al., 1997). These activities influence were performed as described (Vojtek et al., 1993).
cytoskeletal rearrangements, vesicle transport, and
apoptosis, which are largely cytoplasmic events. Some Isolation of Subcellular Fractions and
cytoplasmic targets of PI3K, such as Akt, can translo- Immunohistochemistry
cate to the nucleus, but whether they remain targets of PC12 cell nuclei were isolated, and immunofluorescent staining was
performed essentially as previously described (Ye et al., 1999). ThePI3K in the nucleus is unknown. Thus, nuclear processes
subcellular fractions of PC12 cells were prepared as described (Bur-regulated by the PI3K signaling system have not yet
nett et al., 1998). Subcellular fractions from rat brain were preparedbeen established. In the nervous system, we suggest
as described (Ueda et al., 1979).
that PIKE may be a major, if not the sole mediator of
PI3K activation in the nucleus. Ran is the one other
In Situ HybridizationGTPase that occurs exclusively in the nucleus, but
RNA probes for PIKE were generated by subcloning each open
whether or not it interfaces with PI3K is not known. reading frame from pPC86 or pPC97 into the SalI and NotI sites of
It has been reported that PI3K activity is required for pBS (SK)II1 (Stratagene). Brain slices for in situ hybridization were
the expression of cyclin D1 in many types of cells (Gille prepared and probed as described (Blackshaw and Snyder, 1997).
and Downward, 1999; Takuwa et al., 1999). To ascertain
the role of PIKE and nuclear PI3K in cellular actions of ATP, GTP Binding, and GTPase Assay
Assays of [32P]-g-ATP and [32P]-g-GTP binding to the His-taggedNGF, we infected PC12 cells with dominant-negative
PIKE, and to its N-terminal and C-terminal fragments were per-PIKE (K413AS414N) retrovirus. The PIKE mutant blocks
formed as described (de Rooij et al., 1998). The [35S] GTP-g-S andthe upregulation of cyclin D1 elicited by NGF, but does
ATP-g-S binding to PIKE was determined by use of the nitrocellulosenot affect NGF-induced neurite extension. Though some
filter method under the conditions specified previously (Brandt and
studies have suggested a role for cytoplasmic PI3K ac- Ross, 1985). The GTPase assays were performed essentially as
tivity in NGF-mediated neurite outgrowth (Kimura et al., described (Der et al., 1986).
1994; Jackson et al., 1996; Ashcroft et al., 1999), others
report only a minor potential link of neuronal extension GTP Loading Assays
and PI3K (Kobayashi et al., 1997; Ashcroft et al., 1999). The assays were performed essentially as described (Rosen et al.,
1994) with minor modification. PC12 cells were treated with 50 ng/Our dissociation of NGF-mediated cell cycle arrest and
ml NGF for the indicated times before or after metabolic labeling.neurite outgrowth is consistent with other observations
PC12 cells were metabolically labeled in phosphate-free Dulbecco’s(van Grunsven et al., 1996; Xiong et al., 1997).
modified Eagle’s medium with 0.5 mCi/ml [32P]H3PO4 for 3–4 hr at
378C. Nuclei were isolated as described above, and lysed in 0.5 ml
Experimental Procedures lysis buffer (20 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM MgCl2,
and 1% Triton X-100) containing 5 mg anti-PIKE antibody, and 1:10
Cells and Reagents vol of PBS/1% BSA/10% charcoal slurry was added. Extracts were
PC12 cells were maintained in DMEM with 10% fetal bovine serum rocked at 48C for 30 min and centrifuged for 5 min at 12,000 3 g.
(FBS), 5% horse serum, and 100 units penicillin-streptomycin at Supernatant fluid (0.5 ml) was added to 10 ml of protein A Sepharose
378C with 5% CO2 atmosphere in a humidified incubator. Differentia- and rocked for 30 min at 48C, then washed 3 times with lysis buffer
tion was initiated by addition of 50 ng/ml nerve growth factor (NGF) and once with PBS. Succeeding steps were the same as described.
with culture medium changed to DMEM with 2% horse serum and
1% FBS. NGF, X-Gal, and IPTG were purchased from Boehringer
In Vitro PI3K AssayMannheim. Mouse monoclonal anti-HA, anti-Myc, anti-NuMA, and
Epitope- or His-tagged proteins were precipitated from cell lysatesrabbit polyclonal anti-HA antibodies were supplied by Calbiochem.
as described above, and washed with the following buffers: 3 timesRabbit polyclonal anti-p85 and p110 antibodies were purchased
with buffer A (PBS, 1% NP-40, and 1 mM DTT); 2 times with Bufferfrom Santa Cruz Biotechnology, Inc. Mouse monoclonal anti-GM130
B (PBS, 0.5 M LiCl, and 1 mM DTT); 2 times with Buffer C (10 mMantibody was supplied by Transduction Laboratories Inc. (Lexing-
Tris-HCl [pH 7.4], 0.1 M NaCl, and 1 mM DTT). In experiments usington, KY). -Leu DO supplement, -Leu/-Trp/-His DO supplement, Mini-
His-tagged proteins, the DTT was omitted. The following steps weremal SD Agar Base, and Minimal SD Base for the yeast two-hybrid
exactly as described (Ruderman et al., 1990).screen were from Clontech. Retrovirus cloning vector pDON-A1 was
from Takara Shuzo Co., LTD/Biomedical Group, Shiga, Japan.
Infection of PC12 Cells with p-DON-A1-PIKE
(K413AS414N) Retrovirus
Yeast Two-hybrid Screen
The experiments were performed essentially as described (Mulligan,
Two-hybrid screening was conducted using the Y190 yeast strain
1993; Kim et al., 1998). p-DON-A1 is a 5682 kb plasmid driven by
containing the HIS3 and b-galactosidase (b-gal) reporter genes and
59 HCMV IE (Immediate Early) promoter followed by intron SD/SA
the pPC97 and pPC86 expression vectors. This was performed es-
sequences, as well as retrovirus caspid packaging signals. PIKE
sentially as described (Ye et al., 1999).
(K413AS414N) dominant-negative mutant was cloned into SalI/HpaI
of the SA sequences. The vector contained neomycin and ampicillin
resistance genes as well as bacterial ori. The packaging cell-lineCloning of Full-length PIKE cDNA and Northern Blot Analysis
An adult rat brain cDNA library in lZAPII vector (Stratagene) was Phoenix P293T contained stable transfected and constitutively ex-
pressed retroviral gag and pol genes. Ten micrograms of p-DON-screened using the two-hybrid PIKE fragment, labeled with 32P in a
nick translation system (Boehringer Mannheim). A total of 1.06 3 106 A1-PIKE mutant DNA and 10 mg plasmid DNA expressing vesicular
stomatitis virus G-protein (VSV-G) were cotransfected into Phoenixclones were screened, yielding 7 overlapping inserts. A 2.2 kilobase
open reading frame was identified. A commercial rat multiple tissue P293T cells by the calcium phosphate method. After days, the cul-
ture medium was carefully collected and centrifuged at 6000 3 gNorthern blot (Clonetech) was hybridized according to the manufac-
turer’s recommendations with the N-terminal PIKE probe. The mem- for 30 min to pellet cell debris. The supernatant was filtered with a
0.45 mm filter and centrifuged at 25,000 3 g for 100 min at 48C tobrane was washed three times at 658C in 0.2 3 SSC and 0.1% SDS
solution. pellet virions. After removal of the supernatant, PC12 cell culture
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medium (21 ml) was added to the pellet, which was maintained vival by distinct pathways: possible involvement of PI 3-kinase in
IGF-1 signaling. J. Neurosci. 17, 1548–1560.overnight at 48C. The pellet was then gently resuspended, and 3 ml
aliquots were maintained at 2808C for 24 hr. PC12 cells were in- de Rooij, J., Zwartkruis, F.J., Verheijen, M.H., Cool, R.H., Nijman,
fected with 3 ml virus and 1X Polybrene (4 mg/ml) for 10 hr in the S.M., Wittinghofer, A., and Bos, J.L. (1998). Epac is a Rap1 guanine-
incubator (plates were swirled every 2 hr). Medium (8 ml) was then nucleotide-exchange factor directly activated by cyclic AMP. Nature
added to the plates, and cells were grown to 80% confluence. NGF 396, 474–477.
(50 ng/ml) was then added to the PC12 cells.
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